What's breaking now, across thousands of outlets.
(MedPage Today) -- Patients with non-erosive reflux disease (NERD) who took once-daily tegoprazan -- a novel, fast-acting, oral potassium-competitive acid blocker (P-CAB) -- had a significant reduction in heartburn frequency, a phase III trial...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Genetic testing that helps doctors select the right antidepressant for a patient did not lead to better improvements in depressive symptoms than standard prescriptions based on clinical guidelines…
The protester was hit, kicked, and slapped by police allegedly because he was participating in a video recording documenting police violence towards detainees; his right ear drum was perforated in the…
An assessment for the HSE of the weight-loss drug Wegovy has found that it is cost-effective and value for money, and should be made available to certain public patients, despite the high budget…
More and more of our loved ones could develop dementia , as the number of diagnoses is projected to more than double by 2050, according to new research.
(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics.
Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.
